Study Title
Study Details
Description:
Oncocytic (Hurthle cell) thyroid cancer (HTC) is a rare disease with few treatment options. Researchers are developing a radioactive drug that targets a protein that appears in high numbers on HTC cancer cells. Objective: To test a radioactive drug (177LuDOTA-EB-TATE) in people with HTC.
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases
Contacts:
Joanna Klubo-Gwiezdzinska, M.D.joanna.klubo-gwiezdzinska@nih.gov
(301) 496-5052
Padmasree Veeraraghavan, R.N.padmasree.veeraraghavan@nih.gov
(301) 451-7710
Government Study Link:
NCT06991738 - Click here to see study onClinicalTrials.gov
Drug Details